Leveraging novel RNA biology

---

LEVERaging RNA regulatory mechanisms to drug the undruggable with RNA-targeted therapeutics. We identify novel target RNA biology and design targeted therapeutics to increase, inhibit or restore expression/protein function. We currently have 4 programs in CNS and related disease areas, with the lead program (L5001) going into IND in 2025.

For more information, please contact IR@LevernaTx.com.

---

Leverna Therapeutics
15 Presidential Way
Woburn, MA 01801